NEW YORK: Inovio Pharmaceuticals has received US health regulator’s clearance to begin a mid-stage study of its COVID-19 vaccine candidate, the vaccine maker said on Monday (Nov 16).
The trial for the vaccine, INO-4800, will be funded by the US Department of Defense, the company said.
The US Food …